Optimizing Global Healthcare for Children Through Precision Medicine
The Sanford Children's Genomic Medicine Consortium is transforming care for children through genomic medicine. The Consortium consists of 12 children's hospitals, university medical centers and research universities and is committed to improving children's health by integrating genomic medicine into pediatric care.
Honoring our legacy
Our work is made possible through the vision and philanthropy of T. Denny Sanford. Because of Mr. Sanford’s generosity and belief in innovation, Sanford Children’s and its consortium strive to transform healthcare for children by leveraging genetics and genomics to drive innovative, collaborative research projects, advocating for pediatric precision medicine in public policy and sponsoring joint educational initiatives.
As we honor Mr. Sanford's enduring legacy of philanthropy and innovation, we also recognize H. Eugene Hoyme, MD. His vision, leadership and unwavering commitment to advancing pediatric genetic medicine were instrumental in creating the foundation for the work we do today.
Advancing pediatric precision medicine
The Consortium members are committed to improving the health of all children by integrating genomic medicine into the complete scope of pediatric care. The vision of this group is to:
- Improve diagnosis and treatment of numerous common, rare and undiagnosed childhood conditions
- Enhance pediatric care through innovative joint research programs, advocacy for pediatric precision medicine in public policy and genomic healthcare workforce development
- Strengthen genetic and genomic discovery through access to a large, racially and ethnically unique population
- Bring the benefits of precision medicine to children in marginalized populations worldwide
- Develop productive collaborative relationships with industry and governmental entities
- Provide training in genetics and genomics for physicians, genetic counselors, nurses and other health professionals
Driving discovery through research
Sanford Health has supported innovative collaborative research projects that advance the Consortium’s mission to improve pediatric care through precision medicine. By bringing together leading hospitals and academic medical centers, these efforts are helping improve the diagnosis and treatment of rare diseases, genetic disorders, pediatric cancers and other complex conditions. Funded projects include:
- Improving diagnoses for critically ill newborns through rapid whole-genome sequencing.
- Advancing precision cancer care by identifying genetic drivers of pediatric brain tumors.
- Investigating rare and undiagnosed conditions using comprehensive metabolomic analysis.
- Evaluating new DNA sequencing technologies to improve genetic testing and diagnostic accuracy.
- Applying advanced genomic tools to better understand congenital anomalies and primary immunodeficiencies.
- Implementing pediatric pharmacogenomics to help tailor medications based on a child's genetic profile.
Madison, WI
Tucson, AZ
Denver, CO
Los Angeles, CA
Minneapolis, MN
Palo Alto, CA
Miami, FL
San Diego, CA
Fargo, ND, and Sioux Falls, SD
Seattle, WA
Cape Town, South Africa
Dunedin, New Zealand